What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Fibroblast growth factor, Biochemistry, Cell biology, Internal medicine and Endocrinology.
Moosa Mohammadi has researched Fibroblast growth factor in several fields, including Signal transduction and Bioinformatics.
His biological study deals with issues like Crystal structure, which deal with fields such as Receptor Protein-Tyrosine Kinases, Peptide sequence and Biophysics.
His work on Hormone, FGF21 and Parathyroid hormone as part of general Internal medicine study is frequently linked to Ketogenesis and Energy source, bridging the gap between disciplines.
His Endocrinology research focuses on Growth factor and how it relates to STAT5.
His study looks at the relationship between Fibroblast growth factor receptor and fields such as Fibroblast growth factor receptor 1, as well as how they intersect with chemical problems.
His most cited work include:
- The FGF family: biology, pathophysiology and therapy. (1258 citations)
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21 (1075 citations)
- Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. (1056 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Fibroblast growth factor, Biochemistry, Cell biology, Internal medicine and Endocrinology.
Fibroblast growth factor receptor is the focus of his Fibroblast growth factor research.
His work on Receptor tyrosine kinase, Binding site, Heparin and Plasma protein binding as part of general Biochemistry research is frequently linked to Fusion protein, bridging the gap between disciplines.
He combines subjects such as ROR1, Platelet-derived growth factor receptor, Tyrosine kinase and Proto-oncogene tyrosine-protein kinase Src with his study of Receptor tyrosine kinase.
His work on Klotho, Parathyroid hormone, Kidney and Hypophosphatemia as part of general Internal medicine study is frequently connected to Congenital Hypogonadotropic Hypogonadism, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His study in the field of Hormone is also linked to topics like Kallmann syndrome.
He most often published in these fields:
- Fibroblast growth factor (43.02%)
- Biochemistry (34.08%)
- Cell biology (28.49%)
What were the highlights of his more recent work (between 2014-2021)?
- Cell biology (28.49%)
- Fibroblast growth factor (43.02%)
- Endocrinology (27.93%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cell biology, Fibroblast growth factor, Endocrinology, Internal medicine and Fibroblast growth factor receptor.
In general Cell biology, his work in Receptor tyrosine kinase is often linked to Mechanism linking many areas of study.
His Fibroblast growth factor research incorporates themes from Heparan sulfate, Paracrine signalling, Insulin and Pharmacology.
His Endocrinology research is multidisciplinary, incorporating elements of FGF21 and Fibroblast growth factor 23.
His Fibroblast growth factor receptor study is concerned with the larger field of Biochemistry.
His work on Peptide sequence, Heterologous and Polynucleotide is typically connected to Fusion protein and Linker as part of general Biochemistry study, connecting several disciplines of science.
Between 2014 and 2021, his most popular works were:
- α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling (191 citations)
- The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. (91 citations)
- Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. (49 citations)
In his most recent research, the most cited papers focused on:
Moosa Mohammadi mostly deals with Internal medicine, Endocrinology, Cell biology, Fibroblast growth factor and FGF21.
In the subject of general Internal medicine, his work in Fibroblast growth factor receptor 1, Inflammation and Thermogenesis is often linked to Congenital Hypogonadotropic Hypogonadism, thereby combining diverse domains of study.
His research in the fields of Brown adipose tissue overlaps with other disciplines such as Haematopoiesis.
His Cell biology study combines topics in areas such as Receptor, Tropomyosin receptor kinase C and Fibroblast growth factor receptor.
His Fibroblast growth factor receptor research is included under the broader classification of Biochemistry.
His Fibroblast growth factor research is multidisciplinary, relying on both Fibrosis, Type 1 diabetes, Insulin and Glomerular Mesangial Cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
